Acute promyelocytic leukemia with unusual karyotype

Indian Journal of Human Genetics

Volumn 17, Issue 3, 2011, Pages 235-237

  Gowri, Mangala ^a   Kousar Jahan, S K ^a   Kavitha, ^a   Prasannakumari, ^a   Madhumathi, ^a   Appaji, L ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Acute promyelocytic leukemia; karyotype; RARA

Indexed keywords

HEMOGLOBIN; MYELOPEROXIDASE;

ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CHROMOSOME 15; CHROMOSOME 17Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEVER; GINGIVA BLEEDING; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOCHROMOSOME; KARYOTYPE 46,XY; LEUKEMIA CELL; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MEDICAL HISTORY; METAPHASE; NEUTROPHIL COUNT; PRESCHOOL CHILD; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; SPLENOMEGALY; THROMBOCYTE COUNT; WEAKNESS;

EID: 84856393527     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.92093     Document Type: Article

References (10)

1. Ribeiro RC, Rego E. Management of APL in developing countries: Epidemiology, challenges and opportunities for international collaboration. Hematology Am Soc Hematol Educ Program 2006:162-8.
2. Raimondi SC, Chang MN, Ravindranath Y. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group Study-POG 8821. Blood 1999;94:3707-16.
3. Mrózek K, Heinonen K, Bloomfield CD. Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol 2001;14:19-47. (Pubitemid 32372400)
4. Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002;100: 4325-36. (Pubitemid 35429670)
5. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and post remission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000;96:4075-83.
6. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al. The predictive value of Hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001;98:1312-20.
7. Baranger L, Gardembas M, Hillion J, Foussard C, Ifrah N, Boasson M, et al. Laboratoire de Génétique, CHU Angers, France. Rearrangements of the RARA and PML genes in a cytogenetic variant of acute promyelocytic leukemia. Genes Chromosomes Cancer 1993;6:118-20. (Pubitemid 23064479)
8. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute proyelocytic leukemia: Evolving therapeutic strategies. Blood 2002;99:759-67. (Pubitemid 34525534)
9. Lo-Coco F, Ammatuna E. The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Hematology Am Soc Hematol Educ Program 2006:156-61.
10. Sanz MA. Treatment of acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program 2006:147-55.